Capvis buys Business Systems Integration

The GP deployed capital from Capvis Equity V, which held a final close in September 2018 on €1.2bn and is currently more than 50% deployed. The fund targets controlling positions in companies based across DACH, Benelux and Italy, with enterprise values of €150-500m, operating in the healthcare, industrial and technology sectors.

BSI's management team, led by Jens Thuesen, Christian Rusche and Markus Brunold, will retain a minority stake in the company and continue to lead the business in partnership with Capvis.

The GP intends to accelerate BSI's growth, invest in innovation and further expand the company's software offering. BSI expects to launch two additional products in the coming months as part of its customer suite, which already includes marketing automation platform BSI Studio, AI-dedicated software BSI Brains and clinical trial management software BSI CTMS.

Company
Established in 1996 and headquartered in Baden, BSI is a CRM software provider for the Swiss, German and Austrian markets.

Its tools support companies operating in the banking, insurance and retail sectors in their digitalisation processes, marketing automation and customer experience management. In addition, BSI provides clinical trial management software (CTMS) to life sciences and pharma companies.

BSI employs 320 people in its offices located in Baar, Baden, Bern, Darmstadt, Düsseldorf, Hamburg, Munich and Zurich.

The company generated revenues of CHF 58.6m in 2019, recording a 5.6% increase on the previous year.

People
Capvis Equity – André Perwas (partner).
BSI – Markus Brunold (CEO).

Advisers
Equity – Baer & Karrer (legal).
Company – UBS (M&A); Niederer Kraft Frey (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• DACH
• Technology
• Capvis AG
• Switzerland